RediNews
ETFs Holding ACHN »    ACHN Historical Stock Prices »
ACHN News Video: Fri, Jun 2, 2017, 1:58 PM — Friday's ETF Movers: XBI, XOP


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achillion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. Co.'s focus is on its complement inhibitor platform, directed at developing small molecule compounds to be used in the treatment of immune-related diseases. The alternative pathway plays a role in a number of disease conditions including rare orphan conditions such as paroxysmal nocturnal hemoglobinuria, a blood disorder, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, both kidney diseases, as well as several more prevalent indications. Self directed investors in Achillion Pharmaceuticals Inc will be interested in keeping up with all Achillion Pharmaceuticals Inc news they can find, both ACHN news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ACHN. At RediNews, we simplify this task by presenting both ACHN news releases originating from Achillion Pharmaceuticals Inc itself, and ACHN news from a variety of media outlets. Visitors can browse this news online and through our ACHN RSS news feed.

ACHN News

ACHN News — Articles, Videos, & Press Releases

Implied IEIH Analyst Target Price: $31
Thursday, August 9, 2018, 9:35 AM — ETF Channel
Interesting ACHN Put And Call Options For March 2019
Wednesday, July 25, 2018, 11:18 AM — Stock Options Channel
Achillion's 3rd Factor D Inhibitor Enters Clinical Studies
Wednesday, July 11, 2018, 9:05 AM — Zacks
RAD vs. WBA Which is a Better Stock Ahead of Earnings?
Wednesday, June 27, 2018, 6:08 AM — Zacks
First Week of ACHN August 17th Options Trading
Wednesday, June 20, 2018, 11:09 AM — Stock Options Channel
Add Up The Pieces: VB Could Be Worth $159
Tuesday, February 6, 2018, 8:28 AM — ETF Channel
First Week of ACHN September 21st Options Trading
Thursday, January 25, 2018, 11:26 AM — Stock Options Channel
First Week of February 2018 Options Trading For Achillion Pharmaceuticals (ACHN)
Thursday, December 21, 2017, 10:54 AM — Stock Options Channel
We Did The Math XBI Can Go To $111
Monday, December 18, 2017, 8:28 AM — ETF Channel
Short Interest Moves 18.3% Lower For ACHN
Tuesday, December 12, 2017, 1:54 PM — Market News Video
First Week of June 2018 Options Trading For Achillion Pharmaceuticals (ACHN)
Thursday, November 16, 2017, 10:33 AM — Stock Options Channel
Notable Wednesday Option Activity: NGVC, ACHN, SQ
Wednesday, November 15, 2017, 3:26 PM — Stock Options Channel
Commit To Buy Achillion Pharmaceuticals At $3, Earn 12.9% Annualized Using Options
Thursday, October 26, 2017, 11:30 AM — Stock Options Channel
Notable Monday Option Activity: PII, ACHN, WFT
Monday, October 23, 2017, 3:22 PM — Stock Options Channel
How The Parts Add Up: XBI Headed For $103
Thursday, August 24, 2017, 8:39 AM — ETF Channel
ACHN is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

CHE News
AMSG News
ARTC News
VAR News
PMC News
EBS News
A News
HMSY News
SGYP News
MTD News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ACHN News | www.RediNews.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.